How Much Did TerrAscend Raise?
Funding & Key Investors

TerrAscend has successfully secured a significant capital injection, bringing its total cumulative financing to $540.4M. This latest major strategic investment of $21.7M underscores the company's robust growth trajectory and its ability to attract institutional backing within the competitive North American cannabis sector. By leveraging a mix of debt instruments and share placements, the firm continues to fortify its balance sheet to support its expansive operational footprint across key U.S. and Canadian markets.

The recent infusion of capital serves as a critical milestone, enabling the organization to optimize its debt structure and maintain liquidity as it navigates the complex regulatory landscape of the cannabis industry. This financing round reflects sustained investor confidence in the company's vertically integrated business model and its long-term potential for market leadership.

What is TerrAscend?

TerrAscend
RetailConvenience Stores, Gas Stations & Liquor StoresDrug Stores & Pharmacies

TerrAscend stands as a prominent North American cannabis operator, distinguished by its vertically integrated operations that span cultivation, processing, and manufacturing. The company maintains a significant presence in high-growth markets including Pennsylvania, New Jersey, and California, while also managing licensed production facilities in Canada. Central to its consumer-facing strategy is the award-winning Apothecarium dispensary chain, which provides a premium retail experience that complements the firm's scaled manufacturing capabilities. By controlling the entire value chain, TerrAscend effectively mitigates supply chain volatility and ensures consistent product quality across its diverse portfolio of brands.

How much funding has TerrAscend raised?

TerrAscend has raised a total of $540.4M across 9 funding rounds:

2017

Share Placement

$3.2M

Share Placement

$52.5M

2020

Debt

$58M

Debt

$120M

2022

Debt

$45.5M

2023

Share Placement

$20.5M

2024

Debt

$140M

2025

Debt

$79M

2026

Debt

$21.7M

Share Placement (2017): $3.2M, investors not publicly disclosed

Share Placement (2017): $52.5M, investors not publicly disclosed

Debt (2020): $58M supported by Canopy Growth Corporation

Debt (2020): $120M, investors not publicly disclosed

Debt (2022): $45.5M backed by Pelorus Equity Group

Share Placement (2023): $20.5M, investors not publicly disclosed

Debt (2024): $140M led by FocusGrowth Asset Management

Debt (2025): $79M supported by FocusGrowth Asset Management

Debt (2026): $21.7M, investors not publicly disclosed

Key Investors in TerrAscend

Pelorus Equity Group

Pelorus Equity Group is a specialized commercial real estate lender that provides innovative debt solutions specifically tailored to the cannabis sector. Their expertise in mREIT structures and bridge lending allows them to support complex projects with rapid execution.

FocusGrowth Asset Management

FocusGrowth Asset Management is an institutional investment firm that leverages deep industry expertise to deploy capital into proven cannabis business models. They are recognized for their disciplined approach to risk-adjusted returns and active partnership with management teams.

Canopy Growth Corporation

Canopy Growth Corporation is a leading diversified cannabis company that provides strategic backing and industry-wide influence to support the growth of integrated operators.

What's next for TerrAscend?

Looking ahead, the deployment of this recent capital will likely focus on operational efficiency and the scaling of existing retail and production assets. As the company matures, the strategic use of debt financing suggests a focus on non-dilutive growth, allowing management to pursue market share expansion without compromising equity value. Future initiatives are expected to prioritize the optimization of the Apothecarium retail footprint and the enhancement of manufacturing throughput in key East and West Coast markets. By maintaining a disciplined approach to capital allocation, TerrAscend is well-positioned to capitalize on emerging regulatory shifts and solidify its status as a premier operator in the evolving cannabis landscape.

See full TerrAscend company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Automobile DealersRetailManufacturingMotor VehiclesSporting & Recreational Equipment Retail
Home Improvement & Hardware RetailRetail
Flowers, Gifts & Specialty StoresRetailAdvertising NetworksBusiness Services
Home Improvement & Hardware RetailRetailIndustrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding TerrAscend Financial Insights

What are the most recent funding rounds that TerrAscend has completed, and what were the funding rounds?
TerrAscend has recently completed 3 funding rounds: Debt on Jun 25, 2026, Debt on Jul 9, 2025, Debt on Aug 2, 2024.
What is the total amount of funding TerrAscend has raised to date?
TerrAscend has raised a total of $540.4M in funding to date.
How many funding rounds has TerrAscend completed?
TerrAscend has completed 3 funding rounds.
How much funding did TerrAscend raise in its most recent funding round?
TerrAscend raised $21.7M in its most recent funding round.
Which was the largest funding round in TerrAscend's history?
The largest funding round in TerrAscend's history was $140M.
See more information about TerrAscend